New Survey Reveals Fragmented Cancer Care Pathway in Indonesia and Optimism About Digital Innovations

A recent YouGov survey has shed light on the fragmented cancer care pathway in Indonesia, showcasing critical gaps in the system from screening and diagnosis to treatment and survivorship. The survey, commissioned by Siemens Healthineers, titled ‘Bridging the Gaps: Public Perceptions of the Cancer Care Continuum in Southeast Asia,’ reached over 6,000 individuals across six Southeast Asian nations. The results revealed a strong belief in the importance of early detection (65%), yet only 8% reported low screening uptake.

While 76% of respondents were aware of post-treatment care, a significant 58% lacked understanding of what this care entailed. Confidence in coordinated care and ‘one-stop’ services ranked among the lowest in Southeast Asia at 39% and 31%, respectively. These findings indicate a need for improved communication and education within the cancer care system in Indonesia.

The survey also pointed to a sense of optimism regarding the potential for more coordinated care and the role of digital innovations in enhancing cancer care. With advancements in technology, there is an opportunity to streamline processes, improve access to information, and enhance overall quality of care for cancer patients in the region.

The research underscores the importance of addressing gaps in the cancer care pathway and empowering individuals with knowledge about screening, treatment options, and post-treatment care. By fostering a more integrated and informed approach to cancer care, Indonesia can work towards enhancing outcomes and support for individuals affected by cancer.

In conclusion, the survey highlights the pressing need for a more cohesive and comprehensive approach to cancer care in Indonesia. By bridging the gaps in the system, promoting early detection, and leveraging digital innovations, the country can move towards a more effective and supportive cancer care continuum. This data serves as a call to action for stakeholders in the healthcare sector to collaborate and innovate towards a more robust and integrated cancer care ecosystem.